← Open Payments lookup

MARCY EPSTEIN: Open Payments

NPI 1326371105 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,125 in 68 payments from 7 companies in 2025. Trend: 2023 $715 · 2024 $323 · 2025 $2,125

Food & beverage: $2,038Education: $87
CompanyPaymentsAmount
Alkermes, Inc.17$633
Teva Pharmaceuticals USA, Inc.26$575
E.R. Squibb & Sons, L.L.C.10$404
Otsuka America Pharmaceutical, Inc.11$341
Janssen Pharmaceuticals, Inc2$136
Luye Pharma (USA) Ltd.1$20
Lundbeck LLC1$16

Products named: UZEDY, COBENFY, ARISTADA, LYBALVI, ABILIFY MAINTENA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.

Industry payments across CA — which companies pay providers there.